Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

dc.contributor.authorCicin, Irfan
dc.contributor.authorGumus, Mahmut
dc.contributor.authorUncu, Dogan
dc.contributor.authorOzkan, Metin
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorElkiran, Tamer E.
dc.contributor.authorIsikdogan, Abdurrahman
dc.date.accessioned2024-04-24T17:15:00Z
dc.date.available2024-04-24T17:15:00Z
dc.date.issued2017
dc.departmentDicle Üniversitesien_US
dc.description53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/JCO.2017.35.15_suppl.e15055
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.urihttps://doi.org/10.1200/JCO.2017.35.15_suppl.e15055
dc.identifier.urihttps://hdl.handle.net/11468/18300
dc.identifier.volume35en_US
dc.identifier.wosWOS:000411895707157
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleCharacteristics of Turkish colorectal cancer patients and bevacizumab preference.en_US
dc.titleCharacteristics of Turkish colorectal cancer patients and bevacizumab preference.
dc.typeConference Objecten_US

Dosyalar